top
Search terms
Results 1 - 3 of 3 - ordered by :
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146465 bytes
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146421 bytes
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 183515 bytes